Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

117.39
Delayed Data
As of Dec 06
 +0.83 / +0.71%
Today’s Change
93.05
Today|||52-Week Range
127.00
-1.98%
Year-to-Date
Juno Reports Positive Phase I Study Data on Lymphoma Drug
Dec 06 / Zacks.com - Paid Partner Content
Why bluebird bio Shares Rallied 24.7% In November
Dec 03 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks
Dec 06 / MotleyFool.com - Paid Partner Content
Adventures in CAR-T Racing: Crashes and Curves Edition
Dec 02 / MotleyFool.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content
bluebird Stock Up on Positive Interim Multiple Myeloma Data
Dec 02 / Zacks.com - Paid Partner Content
Why Celgene Shares Jumped 13.9% In November
Dec 05 / MotleyFool.com - Paid Partner Content
Here's Why Bluebird Bio (BLUE) is Rallying Today
Dec 01 / Zacks.com - Paid Partner Content
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
Dec 04 / TheStreet.com - Paid Partner Content
Why bluebird bio, Inc. Stock Is Soaring Today
Dec 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close116.56
Today’s open117.34
Day’s range116.09 - 118.53
Volume4,459,478
Average volume (3 months)4,429,921
Market cap$90.4B
Dividend yield--
Data as of 12/06/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.60%
Earnings growth (next 5 years)+21.20%
Revenue growth (last year)+16.47%
P/E ratio44.6
Price/Sales11.10
Price/Book15.49

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.02+0.05%
BMYBristol-Myers Squibb+0.48+0.86%
ABBVAbbVie+0.76+1.25%
SNYSanofi-0.25-0.61%
Data as of 12/06/2016

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs